TOPIC:

Merck

Watch breaking news videos and read news updates about Merck on FOXBusiness.com.

LATEST VIDEOS

Economy Headed for a Jobless Recovery

11/19/2009|FOX Business Morning

Economy Headed for a Jobless RecoveryCantor Fitzgerald Chief Global Strategist Stephen Pope on why the economy is facing a jobless recovery, not a double-dip recession.

Earl 'The Pearl' Monroe on Diabetes

11/09/2009|Opening Bell

Earl 'The Pearl' Monroe on DiabetesNBA Hall of Famer Earl 'The Pearl' Monroe on fighting diabetes.

Tips for Investors

11/05/2009|FOX Business

Tips for InvestorsMarket Experts Jim Lowell and Charles Robinson on where to invest today.

Election's Effect on Wall Street

11/04/2009|Bulls and Bears

Election's Effect on Wall StreetMerk Investments's Axel Merk on how Wall Street is responding to the election results.

Huntsman on Dangers of Oil Speculation

10/28/2009|Cavuto

Huntsman on Dangers of Oil SpeculationHuntsman Corp. Executive Chairman Jon Huntsman Sr. on the global energy outlook.

Investing in a Risky Market

10/26/2009|Happy Hour on FOX Business

Investing in a Risky MarketMarket expert Axel Merk on where you need to invest today.

Mossberg on Apple's Updated Macs

10/22/2009|FOX Business

Mossberg on Apple's Updated MacsWall Street Journal Personal Technology Columnist Walt Mossberg on Apple's updated computer lines.

Where Are All the Jobs?

10/16/2009|FOX Business

Where Are All the Jobs?FOXBusiness.com LIVE: A look at the good and bad in America's job market

Fear the Rally?

10/12/2009|FOX Business

Fear the Rally?Merk Mutual Funds President Axel Merk on why the current rally has the economy headed toward inflation.

Onyx CEO on the Proteolix Deal

10/12/2009|Opening Bell

Onyx CEO on the Proteolix DealOnyx Pharmaceuticals CEO Tony Coles on the pharmaceutical company's purchase of Proteolix for $276 million.

LATEST STORIES

Merck Receives Recommendation for Fertility Drug

By By Darryl R. Isherwood| FOXBusiness| Markets

FOXBusiness A European advisory committee has recommended approval for Merck & Co.'s (MRK) new fertility drug Elonva. The Committee for ..... approved the treatment would be sold in the European Union. Shares of Merck rose 3% in Friday trading.

Story|11/20/2009

Merck KGaA Cut To Hold From Buy At Citi

By By Barbara Kollmeyer| MarketWatch Pulse| Markets

By Barbara Kollmeyer MarketWatch Pulse MADRID -- German pharmaceutical and chemical company Merck KGaA was downgraded to hold from buy on Friday at Citigroup, which said the risk-reward looks evenly balanced. The rejection

Story|11/20/2009

Abbott Laboratories Reports Positive Results on Niaspan

FOXBusiness| Markets

Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan.

Story|11/16/2009

Merck, Abbott Rise After Study

FOXBusiness| Markets

FOXBusiness Shares of pharmaceutical company Merck (MRK) rose 2% Monday following a study ..... remains challenging, but its importance to Merck diminishes over time." In the drug ..... while Zetia patients had no change. Merck added 2% on Monday to $33.81, and

Story|11/16/2009

Merck, Bristol-Myers Lead Drug Stocks Higher

By By Val Brickates Kennedy| MarketWatch Pulse| Markets

By Val Brickates Kennedy MarketWatch Pulse BOSTON -- Merck & Co. and Bristol-Myers Squibb led drugs stocks higher early ..... Biotechnology Index edged up 0.4% to 895.04. Shares of Merck were up 3% at $34.24, while Bristol-Myers shares gained

Story|11/16/2009

Bausch & Lomb Names Former Schering CEO to Board

FOXBusiness| Markets

maker of personal products announced on Thursday. Hassan served as Schering's CEO from 2003 until the company was acquired by Merck (MRK) in October. Hassan previously worked for Pharmacia, which was sold to Pfizer (PFE) in 2003. On Thursday, Bausch

Story|11/12/2009

Market Winners & Losers: MBIA, Molson Coors

By David O'Brien| FOXBusiness| Markets

shares closed at $57.93, a gain of $3.53 on the day. Merck & Co. (MRK) The pharmaceutical giant gained 6.4% as its ..... closed and the company reiterated its positive financial target. Merck shares ended the session at $32.64, up $1.97 on the day

Story|11/04/2009

Merck Cuts Won't Come in Next Couple Days

By Darryl R. Isherwood| FOXBusiness| Markets

Darryl R. Isherwood FOXBusiness Job cuts are still coming but not this week, Merck & Co.(MRK) Chief Executive Richard Clark said Wednesday, according to Dow Jones. The company, which yesterday acquired Schering

Story|11/04/2009

Merck Leads Drug Stocks Higher

By Val Brickates Kennedy| MarketWatch Pulse| Markets

Val Brickates Kennedy MarketWatch Pulse BOSTON -- Merck led drug stocks higher early Wednesday as the pharmaceutical ..... Biotechnology Index climbed 0.8% to 880.91. Shares of Merck were up almost 3% at $41.46. Shares of Schering-Plough

Story|11/04/2009

Merck, Schering-Plough To Complete Merger Tuesday

By Val Brickates Kennedy| MarketWatch Pulse| Markets

Brickates Kennedy MarketWatch Pulse BOSTON -- Merck & Co. and Schering-Plough Corp. said ..... The combined company will be known as Merck , with shares trading under the symbol ..... for each Schering-Plough share. Each Merck share will automatically convert to one

Story|11/03/2009